The pitfall of cohort isolation in an outbreak of linezolid-resistant, vancomycin-resistant enterococci

Clin Microbiol Infect. 2019 Dec;25(12):1568-1569. doi: 10.1016/j.cmi.2019.08.014. Epub 2019 Aug 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology
  • Cross Infection / microbiology*
  • Cross Infection / transmission
  • Disease Outbreaks*
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Drug Resistance, Multiple, Bacterial / genetics
  • Gram-Positive Bacterial Infections / drug therapy
  • Gram-Positive Bacterial Infections / epidemiology
  • Gram-Positive Bacterial Infections / microbiology*
  • Gram-Positive Bacterial Infections / transmission
  • Humans
  • Infection Control / methods*
  • Linezolid / pharmacology*
  • Linezolid / therapeutic use
  • Microbial Sensitivity Tests
  • Mutation
  • RNA, Ribosomal, 23S / genetics
  • Vancomycin-Resistant Enterococci / drug effects*
  • Vancomycin-Resistant Enterococci / genetics*

Substances

  • Anti-Bacterial Agents
  • RNA, Ribosomal, 23S
  • Linezolid